Deceased Organ Donor Interventions to Protect Kidney Graft Function

NCT02525510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1427

Last updated 2022-06-14

No results posted yet for this study

Summary

To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.

Conditions

  • Brain Death
  • Organ Donation
  • Organ Transplant Failure or Rejection
  • Delayed Graft Function

Interventions

OTHER

Pump Eligible - Normothermia - Pump Both Kidneys

Normothermia and Machine Perfusion Deceased Donors will be kept normothermic (36.5-37.5 C) prior to organ recovery. Recovered kidneys will receive machine perfusion prior to implantation.OPO's protocol

OTHER

Pump Eligible - Hypothermia and Pump Right Kidney

Deceased Donors will be kept mildly hypothermic (34-35 C) for at least 12 hours prior to organ recovery. Right Kidney will receive machine perfusion prior to implantation and the Left Kidney will receive cold storage. Recovered kidneys will be placed in University of Wisconsin for cold storage until reimplantation.

OTHER

Pump Eligible - Hypothermia and Pump Left Kidney

Deceased Donors will be kept mildly hypothermic (34-35 C) for at least 12 hours prior to organ recovery. Left Kidney will receive machine perfusion prior to implantation and the Right Kidney will receive cold storage.

OTHER

Not Pump Eligible - Normothermia

Deceased Donors will be kept normothermic (36.5-37.5 C) prior to organ recovery. Pulsatile Perfusion of kidney grafts based on the respective OPO's protocol

OTHER

Not Pump Eligible - Hypothermia

Deceased Donors will be kept mildly hypothermic (34-35 C) for at least 12 hours prior to organ recovery.

Sponsors & Collaborators

Principal Investigators

  • Darren Malinoski, MD · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-26
Primary Completion
2022-06-01
Completion
2022-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02525510 on ClinicalTrials.gov